Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Adefovir dipivoxil, 10 mg p.o. daily, is safe and effective in the treatment of chronic hepatitis due to HBV, regardless of the presence or absence of HBeAg, and it did not select resistant mutants after 48 weeks of administration.

Adefovir Dipivoxil Treatment of Chronic Hepatitis Due to HBV Infection